Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Gross Profit (2024 - 2025)

CG Oncology's Gross Profit history spans 2 years, with the latest figure at -$748000.0 for Q4 2025.

  • For Q4 2025, Gross Profit fell 264.04% year-over-year to -$748000.0; the TTM value through Dec 2025 reached -$160000.0, changed N/A, while the annual FY2025 figure was -$607000.0, 153.29% down from the prior year.
  • Gross Profit reached -$748000.0 in Q4 2025 per CGON's latest filing, down from $89000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $456000.0 in Q4 2024 to a low of -$748000.0 in Q4 2025.